American Heart Journal
Volume 141, Issue 6 , Pages 940-943 , June 2001

Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty

Received 13 November 2000 ,Accepted 19 January 2001.

References 

  1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  2. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol. 1987;255:H1470–H1476
  3. Deutsch E, Berger M, Kussmaul WG, et al.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation. 1990;82:2044–2051
  4. Airaksinen KEJ, Huikuri HV. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J Am Coll Cardiol. 1997;29:1035–1038
  5. Ashikaga T, Nishizaki M, Arita M, et al.  Increased QTc dispersion predicts lethal ventricular arrhythmias during coronary angioplasty. Am J Cardiol. 1998;82:814–816
  6. Yellon DM, Baxter GF, Garcia-Dorado D, et al.  Ischaemic preconditioning: present position and future directions. Cardiovasc Res. 1998;37:21–33
  7. Cribier A, Korsatz L, Koning R, et al.  Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol. 1992;20:578–586
  8. Okishige K, Yamashita K, Yoshinaga H, et al.  Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty. J Am Coll Cardiol. 1996;28:70–73
  9. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 1990;63:342–344
  10. Highman PD, Furniss SS, Campbell RWF. QT dispersion and components of the QT interval in ischemia and infarction. Br Heart J. 1995;73:32–36
  11. Matsubara T, Minatoguchi S, Matsuo H, et al.  Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol. 2000;35:345–351
  12. Rentrop KP, Cohen M, Blanke H, et al.  Changes in collateral filling immediately following controlled coronary artery occlusion by an angioplasty balloon in man. J Am Coll Cardiol. 1985;5:587–592
  13. Liu Y, Sato T, Rourke B, et al.  Mitochondrial ATP-dependent potassium channels—novel effectors of cardioprotection?. Circulation. 1998;97:2463–2469
  14. Sato T, Sasaki N, O’Rourke B, et al.  Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514–518
  15. Auchampach JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol. 1992;20:765–771
  16. Tomai F, Crea F, Gaspardone A, et al.  Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation. 1994;90:700–705
  17. Uchida Y, Yoshimoto N, Murao S. Effect of 2-nicotinamidoethyl nitrate (SG-75) on coronary circulation. Jpn Heart J. 1978;19:112–124
  18. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J–24J
  19. Tomai F, Crea F, Gaspardone A, et al.  Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol. 1993;22:1892–1896

☆ Reprint requests: Toru Kato, MD, Third Department of Internal Medicine, Saitama Medical Center, Saitama Medical School, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan. E-mail: torumed3@saitama-med.ac.jp

PII: S0002-8703(01)88266-1

doi: 10.1067/mhj.2001.114369

American Heart Journal
Volume 141, Issue 6 , Pages 940-943 , June 2001

Article Tools

* Image Usage & Resolution